More articles from Article

Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment
Suzanne D. Westfall, Michael K. Skinner

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1764-1771; DOI: 10.1158/1535-7163.MCT-05-0192
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
Roberto R. Rosato, Jorge A. Almenara, Sonia C. Maggio, Peter Atadja, Ruth Craig, Julie Vrana, Paul Dent, Steven Grant

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1772-1785; DOI: 10.1158/1535-7163.MCT-05-0157
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion
Alexandre Kaliski, Laurence Maggiorella, Keith A. Cengel, Denis Mathe, Valerie Rouffiac, Paule Opolon, Nathalie Lassau, Jean Bourhis, Eric Deutsch

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1717-1728; DOI: 10.1158/1535-7163.MCT-05-0179
Determination of the importance of the stereochemistry of psorospermin in topoisomerase II–induced alkylation of DNA and in vitro and in vivo biological activity
Ingrid M. Fellows, Michael Schwaebe, Thomas S. Dexheimer, Hariprasad Vankayalapati, Mary Gleason-Guzman, Jeffrey P. Whitten, Laurence H. Hurley

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1729-1739; DOI: 10.1158/1535-7163.MCT-05-0183
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma
Dimpy Koul, Ruijun Shen, Sherry Bergh, Yiling Lu, John F. de Groot, Ta Jen Liu, Gordon B. Mills, W.K. Alfred Yung

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1681-1688; DOI: 10.1158/1535-7163.MCT-05-0258
The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
Linda C. Hsi, Xiaopei Xi, Yuanqing Wu, Scott M. Lippman

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1740-1746; DOI: 10.1158/1535-7163.MCT-05-0218
Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model
Romyla Ilagan, Liquin Joann Zhang, Jill Pottratz, Kim Le, Sussan Salas, Meera Iyer, Lily Wu, Sanjiv S. Gambhir, Michael Carey

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1662-1669; DOI: 10.1158/1535-7163.MCT-05-0197
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Kazuki Yamanaka, Palma Rocchi, Hideaki Miyake, Ladan Fazli, Bob Vessella, Uwe Zangemeister-Wittke, Martin E. Gleave

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1689-1698; DOI: 10.1158/1535-7163.MCT-05-0064
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
Shivendra V. Singh, Yan Zeng, Dong Xiao, Victor G. Vogel, Joel B. Nelson, Rajiv Dhir, Yamini B. Tripathi

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1747-1754; DOI: 10.1158/1535-7163.MCT-05-0223
Biological and molecular properties of a new α_vβ₃/α_vβ₅ integrin antagonist
Laura Belvisi, Teresa Riccioni, Marcella Marcellini, Loredana Vesci, Ilaria Chiarucci, Daniela Efrati, Donatella Potenza, Carlo Scolastico, Leonardo Manzoni, Katia Lombardo, M. Antonietta Stasi, Augusto Orlandi, Alessandro Ciucci, Beatrice Nico, Domenico Ribatti, Giuseppe Giannini, Marco Presta, Paolo Carminati, Claudio Pisano

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1670-1680; DOI: 10.1158/1535-7163.MCT-05-0120

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT